Eligible etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
Eligible etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

1 Şubat 2017 Çarşamba

NHS ID scheme could deter eligible patients, say MPs

A pilot scheme in which patients are asked to show two forms of identification before receiving NHS treatment could compromise access to care, parliament’s spending watchdog has said.


The public accounts committee urged caution before officials extend the scheme, saying it could lead to entitled patients staying away from hospitals. The MPs have also told the Department of Health to take urgent action to renew a “chaotic” system of recovering money from so-called health tourists.


Trusts are supposed to charge visitors from outside the European Economic Area and Switzerland for non-emergency hospital treatment. For patients from the EEA and Switzerland, trusts should recoup their costs through an insurance scheme.


In November the department’s permanent secretary, Chris Womald told the committee that ID checks were taking place at a hospital trust in Peterborough, an area with a high number of immigrants.


Patients are asked to show passports and utility bills but the committee says in a report: “These documents do not demonstrate entitlement to free NHS care. The biggest challenge is that there is no single easy way to prove entitlement.”


The MPs also point out that some UK-based patients would struggle to bring in such documents. “We are conscious that some people who live in this country and are eligible for free healthcare may struggle to provide passports and utility bills and it is important that their access to care is not compromised,” the report added. “The department should consider a system that would allow verification without compromising patient care.”


The report recommends extending the use of NHS numbers and electronic patient records. “This could help tackle both the very low levels of cost recovery for European Economic Area and Swiss patients, and the problem that some people resident in this country may find it hard to show documents that indicate their entitlement,” it said.


In evidence to the committee, the health department admitted “very little happened” for more than 30 years after legislation was introduced in 1982 to recover money from overseas patients.


In 2014/15 the UK recovered £50m from other European countries and paid out £675m. The health department has set a target to recover up to £500m a year by 2017/18, but forecasts that only £346m will be charged.


The report calls on GPs to do more to help identify patients who should be charged for NHS care following a referral to hospital. It points to a wide variation between NHS trusts in debt collection rates, from 15% to 100%. Just 10 out of 154 hospitals accounted for half of the charges to visitors from outside the EEA – the EU plus Norway, Iceland and Liechtenstein – and Switzerland in 2015/16.


Departmental officials say there will be policy changes and improvements to IT, but admit they have much more to do to enforce the rules.


A health department spokeswoman said other trusts were trialling the scheme piloted in Peterborough, and still more were exploring their own ways of identifying patients.


“We will be announcing further steps very shortly to recover up to £500m a year by the middle of this parliament,” she added.


Prof Helen Stokes-Lampard, chair of the Royal College of GPs, welcomed the committee’s report. She said: “It is the role of GPs and our teams to deliver care to our patients, free at the point of need, regardless of their individual circumstances. We must stop perpetuating this idea that general practice should, in whatever way, assist with border control.”


Dr Mark Porter, chair of the British Medical Association, said his members had also raised concerns. “Any charging systems should not prevent sick and vulnerable patients receiving necessary care, otherwise there may be serious consequences for their health and that of the public in general,” he said.


The MPs’ report concludes that the department should publish an action plan by June complete with milestones and performance measures for increasing the amount of revenue from foreign users of the NHS.


Meg Hillier, the chair of the public accounts committee, said it was unacceptable that so much money owed should continue to go uncollected. “This is a problem for the health service as a whole and work to put it right must be driven by central government,” she said.


“We are concerned that financial progress to date does not reflect meaningful progress with implementing the rules and the Department for Health and NHS have much to do if they are to meet their target for cost recovery.”



NHS ID scheme could deter eligible patients, say MPs

19 Mart 2014 Çarşamba

12.8 Million Much more Grownups Now Eligible For Statin Treatment

Millions more folks are now eligible for statin treatment under the new cholesterol guideline, in accordance to a new estimate published in the New England Journal of Medicine.


Under the earlier guideline statins have been indicated for main and secondary prevention based largely on LDL cholesterol amounts. The new guideline, announced final year, spots significantly significantly less emphasis on LDL and instead spots a significantly greater emphasis on the future chance of people for heart disease and stroke. The most critical modify is in major prevention. Even if they have LDL cholesterol ranges as lower as 70 mg dl, men and women with out established cardiovascular ailment are now eligible for statin therapy if they have either diabetes or a 10-12 months estimated chance of CV disease of 7.5%.


There have been several attempts to quantify just how numerous more individuals are now eligible for statin treatment under the new guideline. Now in the new paper in NEJM, Michael Pencina and colleagues estimate that the new guideline outcomes in a net enhance of twelve.8 million folks who are now eligible for statins. Most of the newly eligible folks are older grownups with no cardiovascular ailment.


The researchers extrapolated from information from a representative sample of the US population (the Nationwide Well being and Nutrition Examination Surveys, or NHANES) and calculated the variety of grownups forty-75 years of age who would be eligible for statin treatment below the outdated guideline and the new guideline:



  • Beneath the old guideline 43.two million adults, or 37.five% of the population, had been eligible for statins.

  • Beneath the new guideline this increases to 56 million (48.6%). Three out of 5 of the newly eligible patients would be males and their median age would be 63.four years.

  • The net improve in 12.eight million comes mainly from primary prevention–  10.four million.

  • Most of the boost happens in older grownups, among 60 and 75 years. Just below half (47.eight%) of this population was eligible for statins in the earlier guideline. Now far more than three-quarters (77.three%) of this age group are eligible.

  • Decreasing the treatment threshold to a 10-12 months danger commencing at five%, which the guidelines deem “reasonable,” would increase eligibility to 38.4% of grownups among forty and 60 and 87.four% of grownups 60-75.

  • By growing the amount of people eligible for treatment method,  the new guideline has increased sensitivity– that is, it will consequence in far more individuals being taken care of who would otherwise have gone on to have a cardiovascular event– but also decreased specificity– much more folks will acquire treatment who would not have had an occasion.

  • The authors estimated that the improved number of individuals taking statins would result in 475,000 fewer  events– almost all (90%) coming from the group of older adults.


In an email interview, Allan Sniderman, 1 of the senior authors of the paper, explained that the increase in the population eligible for therapy “has main consequences for cost and medicalization.” He agreed with other observers that the seven.5% threshold cutoff “is arbitrary.” “The way out is to much better define danger. That is in which we want to move forward,” he said.


An option to the “risk-based mostly approach” of the new guideline, Sniderman stated, is “a cause-based technique in which we recognize and treat the causes in order to avert the intramural atherosclerotic ailment that will make the clinical occasions.” But this approach, he acknowledged, will demand  more investigation just before  being adopted by long term suggestions.


The NEJM paper fails to get into account the more subjective side of the new guideline, said Harlan Krumholz in an e-mail. “The guideline recommendation is meant to be just that – a recommendation about a threshold that might make sense to use in a treatment method determination. The suggestions are clear that the patient’s preference is what issues most. So it is really impossible to know if far more individuals will be taking statins.”



12.8 Million Much more Grownups Now Eligible For Statin Treatment